Zobrazeno 1 - 10
of 740
pro vyhledávání: '"Freudenthal, B"'
Autor:
Freudenthal, B, Shetty, S, Butterfield, NC, Logan, JG, Han, CR, Zhu, X-G, Astapova, I, Hollenberg, AN, Cheng, S-Y, Bassett, JHD, Williams, G
Background Thyroid hormones act in bone and cartilage via thyroid hormone receptor α (TRα). In the absence of T3, TRα interacts with co-repressors, including nuclear receptor co-repressor-1 (NCoR1), which recruit histone deacetylases (HDACs) and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::b6ee2132f144c62d9ec0fd742d62373a
http://hdl.handle.net/10044/1/67910
http://hdl.handle.net/10044/1/67910
Autor:
Todorov G; Department of Medicine for the Elderly, West Middlesex University Hospital, Isleworth, UK., Brook S; Department of Medicine for the Elderly, Imperial College Healthcare NHS Trust, London, UK., Quah Qin Xian N; Department of Acute Medicine, Imperial College Healthcare NHS Trust, London, UK., Von Widekind S; Department of Acute Medicine, Imperial College Healthcare NHS Trust, London, UK., Freudenthal B; Endocrine Bone Unit, Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.; Section of Endocrinology & Investigative Medicine, Imperial College London, London, UK., Comninos AN; Endocrine Bone Unit, Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK a.comninos@imperial.ac.uk.; Section of Endocrinology & Investigative Medicine, Imperial College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2022 Jul 12; Vol. 12 (7), pp. e060282. Date of Electronic Publication: 2022 Jul 12.
Autor:
Freudenthal, B., Williams, G.R.
Publikováno v:
In Clinical Oncology May 2017 29(5):325-328
Autor:
Freudenthal, B, Williams, GR
Differentiated thyroid cancer is the commonest form of thyroid cancer, and its prognosis is favourable in the majority of cases. Suppression of thyroid stimulating hormone (TSH) by supra - physiological thyroid hormone replacement has been the mainst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::c1c5bc2927a5eb29c52222641cac083a
http://hdl.handle.net/10044/1/43394
http://hdl.handle.net/10044/1/43394
Autor:
Freudenthal, B, Logan, J, Sanger Institute Mouse Pipelines2, Croucher, PI, Williams, GR, Bassett, JHD
Publikováno v:
R46
R31
R31
The genetic determinants of osteoporosis remain poorly understood, and there is a large unmet need for new treatments in our ageing society. Thus, new approaches for gene discovery in skeletal disease are required to complement the current genome-wid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::e46cbf5a38cc28d3c7ca208c21f5408e
http://hdl.handle.net/10044/1/39207
http://hdl.handle.net/10044/1/39207
Autor:
Freudenthal, B.
Publikováno v:
Archiv für Rechts- und Wirtschaftsphilosophie, 1908 Jan 01. 2(2), 259-271.
Externí odkaz:
https://www.jstor.org/stable/23685479
Autor:
Ma, Ying1 (AUTHOR), Guo, Jiarong1 (AUTHOR), Rao, Haipeng1 (AUTHOR), Xin, Jingyu1 (AUTHOR), Song, Xinyi1 (AUTHOR), Liu, Rui1 (AUTHOR), Shao, Shan1 (AUTHOR), Hou, Jiajia1 (AUTHOR), Kong, Liyu1 (AUTHOR), Hu, Zhigang1 (AUTHOR), He, Lingfeng1 (AUTHOR), Pan, Feiyan1 (AUTHOR) panfeiyan@njnu.edu.cn, Guo, Zhigang1 (AUTHOR) guo@njnu.edu.cn
Publikováno v:
Journal of Extracellular Vesicles. Sep2024, Vol. 13 Issue 9, p1-21. 21p.
Autor:
Freudenthal B; Clinical Research Fellow, Imperial College London, London, W12 0NN, UK. Electronic address: b.freudenthal@imperial.ac.uk.
Publikováno v:
Lancet (London, England) [Lancet] 2020 Oct 24; Vol. 396 (10259), pp. 1328-1329.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Freudenthal B; 1 Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, United Kingdom., Shetty S; 1 Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, United Kingdom., Butterfield NC; 1 Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, United Kingdom., Logan JG; 1 Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, United Kingdom., Han CR; 2 Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Zhu X; 2 Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Astapova I; 3 Endocrinology, Metabolism and Nutrition, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Hollenberg AN; 4 Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine and New York Presbyterian/Weill Cornell Medical Center, New York, New York., Cheng SY; 2 Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Bassett JHD; 1 Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, United Kingdom., Williams GR; 1 Molecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London, United Kingdom.
Publikováno v:
Thyroid : official journal of the American Thyroid Association [Thyroid] 2019 May; Vol. 29 (5), pp. 726-734. Date of Electronic Publication: 2019 Mar 14.